SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

SVB Leerink Maintains Market Perform on Nektar Therapeutics, Lowers Price Target to $20

SVB Leerink analyst Daina Graybosch maintains Nektar Therapeutics (NASDAQ:NKTR) with a Market Perform and lowers the price target from $21 to $20.

05/10/2021 06:19
SVB Leerink analyst Daina Graybosch maintains Nektar Therapeutics (NASDAQ:NKTR) with a Market Perform and lowers the price target from $21 to $20.